| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-15 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-08 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.26 | 3e-07 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.15 | 0.0008 |